AI assistant
Emcure Pharmaceuticals Limited — Call Transcript 2025
May 22, 2025
60464_rns_2025-05-22_6b6f72dd-2b2f-4e71-942f-3374f6fdaadd.pdf
Call Transcript
Open in viewerOpens in your device viewer
Emcure
Ref: EPL/CS/SE/0034/2025
Date: May 22, 2025
To,
National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai - 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE
Dear Sir/Madam,
Subject: Audio recording of Earnings Call – Q4 FY25
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated May 13, 2025 regarding earnings call, the audio recording of the call held today i.e. on May 22, 2025, is available on our website. The said audio recording can be accessed through the below web address:
https://www.emcure.com/wp-content/uploads/2025/05/Audio-file-4QFY25.mp3
You are requested to take the above information on your records.
Thanking you,
For Emcure Pharmaceuticals Limited
CHETAN Digitally signed by CHETAN RAJENDRA RAJENDRA SHARMA SHARMA Date: 2025.05.22 18:19:10 +05'30' Chetan Sharma Company Secretary & Compliance Officer Membership Number: F8352
Emcure Pharmaceuticals Limited
Registered Office : Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060
E-mail: [email protected] Website: www.emcure.com CIN: L24231PN1981PLC024251